Evans L. Sagwa - Publications

The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis.

Journal: PloS one

Published: November 17, 2020

Implementing an Integrated Pharmaceutical Management Information System for Antiretrovirals and Other Medicines: Lessons From Namibia.

Journal: Global health, science and practice

Published: April 27, 2018

Renal function of MDR-TB patients treated with kanamycin regimens or concomitantly with antiretroviral agents.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: January 04, 2018

Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia.

Journal: Patient preference and adherence

Published: December 07, 2016

An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implications.

Journal: International journal of clinical practice

Published: September 08, 2016

Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.

Journal: Pharmacoepidemiology and drug safety

Published: August 24, 2016

Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis.

Journal: Drug safety

Published: June 18, 2016

Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.

Journal: PloS one

Published: April 25, 2016

Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia.

Journal: Pharmacoepidemiology and drug safety

Published: October 29, 2015

Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.

Journal: BMC pharmacology & toxicology

Published: August 18, 2015

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study.

Journal: Journal of pharmaceutical policy and practice

Published: January 28, 2014

Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infection.

Journal: Drug safety

Published: August 07, 2013